ArticleBiomolecules2021

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.

Yawei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.